Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
- 27 November 2021
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 102 (3), 115609
- https://doi.org/10.1016/j.diagmicrobio.2021.115609
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic InstitutionJournal of Clinical Microbiology, 2020
- Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic PatientsJournal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19Journal of Clinical Microbiology, 2020
- Commercial Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG CoV Extended Panel and ID NOW COVID-19 TestArchives of Pathology & Laboratory Medicine, 2020
- How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratoryDiagnostic Microbiology and Infectious Disease, 2020
- Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2American Journal of Clinical Pathology, 2020
- Evaluation of the COVID19 ID NOW EUA assayJournal of Clinical Virology, 2020
- Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2Journal of Clinical Virology, 2020